Studies on the FTO rs9939609, the MC4R rs17782313, and the PPAR-γ rs1801282 polymorphisms conducted so far, focused mainly on searching for the relationships between these gene variants and symptoms of metabolic disorders (obesity, insulin resistance, hypertension, and hyperlipidemia). The gene discussed is PPARG; the disease is hyperlipidemia.